Skip to main content
Natco Pharma Ltd. logo

Natco Pharma Ltd. — Investor Relations & Filings

Ticker · NATCOPHARM ISIN · INE987B01026 LEI · 33580086GIBRWXSNGG39 BSE.NS Manufacturing
Filings indexed 1,707 across all filing types
Latest filing 2021-08-13 Regulatory Filings
Country IN India
Listing BSE.NS NATCOPHARM

About Natco Pharma Ltd.

https://www.natcopharma.co.in/

Natco Pharma Ltd. is a vertically integrated organization focused on the development, manufacturing, and marketing of complex generics and active pharmaceutical ingredients (APIs). The company specializes in niche therapeutic areas, maintaining a leadership position in oncology and a significant presence in specialty segments such as hepatology, cardiology, and diabetology. Natco is recognized for its expertise in high-barrier-to-entry products, including complex oral solids and injectables. Its business model emphasizes research and development to deliver affordable versions of life-saving medicines globally. With a robust portfolio of finished dosage formulations and a strong supply chain for APIs, the company serves diverse international markets, including North America, Europe, and emerging economies, through strategic partnerships and direct distribution channels.

Recent filings

Filing Released Lang Actions
Natco Pharma Ltd has informed BSE that the Company has fixed August 25, 2021 as the Record Date for the purpose of Payment of Interim Dividend.The payment of said interim dividend ....
Regulatory Filings
2021-08-13 English
Updates
Regulatory Filings
2021-08-12 English
Dividend
Regulatory Filings
2021-08-12 English
Declared an Interim Dividend of Rs.2/- each for the Financial year 2021-22
Regulatory Filings
2021-08-12 English
Record Date
Regulatory Filings Classification · 95% confidence The document text is extremely short (64 characters) and contains no substantive content, financial data, or any indication of report type. It only includes a placeholder for an omitted picture and no other information. Given the lack of content, it cannot be classified as a full report or detailed filing. According to the rules, such minimal content with no report details defaults to Regulatory Filings (RNS) as a fallback category.
2021-08-12 English
Un Audited Financial Results for the quarter ended June 30, 2021 under Regulation 33 of SEBI (LODR) Regulations, 2015
Regulatory Filings
2021-08-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.